Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-23

FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for XANAX XR (alprazolam) filed by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XANAX XR (alprazolam)

Snippet

SUPPL AP for XANAX XR (ALPRAZOLAM)